Teva Pharmaceutical Industries Newsroom

UBS Upgrades Teva Pharmaceutical Industries(TEVA.US) to Buy Rating, Maintains Target Price $26

Futu NewsNov 11 17:33

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 11 16:32

UBS Downgrades Teva Pharmaceutical Industries(TEVA.US) to Hold Rating, Maintains Target Price $26

Futu NewsNov 8 21:32

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23

Futu NewsNov 7 20:31

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 7 16:31

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $25

Futu NewsNov 6 16:33

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $25

Futu NewsOct 23 15:33

Teva Pharmaceutical Indus Analyst Ratings

BenzingaOct 21 22:38

J.P. Morgan Maintains Teva Pharmaceutical Industries(TEVA.US) With Hold Rating, Raises Target Price to $18

Futu NewsOct 21 20:36

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26

Futu NewsOct 16 16:32

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsOct 2 08:32

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 24 18:32

Barclays Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $22

Futu NewsSep 24 15:32

Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsSep 23 20:33

BofA Securities Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Announces Target Price $22

Futu NewsSep 19 22:31

Jefferies Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $23

Futu NewsSep 9 20:33

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Maintains Target Price $26

Futu NewsSep 9 16:31

Organon Downgraded, Amneal Upgraded as J.P. Morgan Reviews Specialty Pharma

Seeking AlphaSep 6 20:42

UBS Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $26

Futu NewsSep 3 22:31

Piper Sandler Maintains Teva Pharmaceutical Industries(TEVA.US) With Buy Rating, Raises Target Price to $23

Futu NewsAug 28 20:33